Jerome A. Zack

Activation of CD8 T cells induces expression of CD4, which functions as a chemotactic receptor.

Effect of latent human immunodeficiency virus infection on cell surface phenotype.

Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.

Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes.

Effects of prostratin on T-cell activation and human immunodeficiency virus latency.

Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype.

HIV type 1 infection alters cytokine mRNA expression in thymus.

Human immunodeficiency virus type 1 infection and replication in normal human oral keratinocytes.

HIV-1 infection in peripheral blood lymphocytes (PBLs) exposed to alcohol.

Molecular characterization, reactivation, and depletion of latent HIV.

Controlling false-negative errors in microarray differential expression analysis: a PRIM approach.

Identification of T cell-signaling pathways that stimulate latent HIV in primary cells.

Psychological risk factors for HIV pathogenesis: mediation by the autonomic nervous system.

Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.

Public health. A sound rationale needed for phase III HIV-1 vaccine trials.

The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection.

Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients.

Stress-induced enhancement of NF-kappaB DNA-binding in the peripheral blood leukocyte pool: effects of lymphocyte redistribution.

CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection.

Alcohol enhances HIV type 1 infection in normal human oral keratinocytes by up-regulating cell-surface CXCR4 coreceptor.

Expression-based monitoring of transcription factor activity: the TELiS database.

The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral and cellular antigens.

Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus.

beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA.

Rapid size dependent deletion of foreign gene sequences inserted into attenuated HIV-1 upon infection in vivo: implications for vaccine development.

Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection.

PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry.

Rapid expression of human immunodeficiency virus following activation of latently infected cells.

T lineage differentiation from human embryonic stem cells.

CD4 expression on activated NK cells: ligation of CD4 induces cytokine expression and cell migration.

A plea for justice for jailed medical workers.

Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells.

Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques.

Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo.

Primary cell model for activation-inducible human immunodeficiency virus.

Generation of T lineage cells from human embryonic stem cells in a feeder free system.

Eradication of HIV: current challenges and new directions.

Short communication: Activating stimuli enhance immunotoxin-mediated killing of HIV-infected macrophages.

A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors.

Differentially stimulated CD4+ T cells display altered human immunodeficiency virus infection kinetics: implications for the efficacy of antiviral agents.

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.

A self-renewal program controls the expansion of genetically unstable cancer stem cells in pluripotent stem cell-derived tumors.

CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function.

Human immunodeficiency virus integration efficiency and site selection in quiescent CD4+ T cells.

Animal models of HIV-1 latency and persistence.

Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice.

A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.

Differential expression and interaction of host factors augment HIV-1 gene expression in neonatal mononuclear cells.

Macrophage differentiation from embryoid bodies derived from human embryonic stem cells.

Gene expression and transcription factor profiling reveal inhibition of transcription factor cAMP-response element-binding protein by gamma-herpesvirus replication and transcription activator.

CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes.

Quiescent T cells and HIV: an unresolved relationship.

Female human iPSCs retain an inactive X chromosome.

Stem cell-based approaches to treating HIV infection.

Establishment and maintenance of HIV latency: model systems and opportunities for intervention.

Activation of latent HIV using drug-loaded nanoparticles.

Single mutations in HIV integrase confer high-level resistance to raltegravir in primary human macrophages.

Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt.

HIV latency is influenced by regions of the viral genome outside of the long terminal repeats and regulatory genes.

HIV latency in the humanized BLT mouse.

Genome-wide binding map of the HIV-1 Tat protein to the human genome.

Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells.

In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells.

Virological evidence supporting the use of raltegravir in HIV post-exposure prophylaxis regimens.

Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro.

From skin biopsy to neurons through a pluripotent intermediate under Good Manufacturing Practice protocols.